GlassScriptPhysician profile
Jaffar A Raza
NPI 1326119637
$44,946.48
in general payments reported to CMS, 2019-2025
36 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,343 · 2020: $3,051 · 2021: $2,054 · 2022: $14K · 2023: $3,883 · 2024: $1,956 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000 · Food and Beverage: $4,265 · Travel and Lodging: $3,276 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
| Food and Beverage | $4,265.33 |
| Travel and Lodging | $3,276.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,230.52 | 2021-2025 | Closurefast, Onyx Frontier, Corevalve Evolut R |
| Abbott Laboratories | $12,533.57 | 2019-2025 | Perclose Proglide, Supera, Esprit |
| Recor Medical INC | $8,835.75 | 2025 | Paradise Ultrasound Renal Denervation System |
| Boston Scientific Corporation | $2,005.37 | 2019-2025 | Varithena Administration Pack, General - Therapies, Avvigo Guidance System |
| Medtronic Vascular, INC. | $1,609.72 | 2019-2020 | |
| Cook Incorporated | $591.15 | 2024 | Cook Celect |
| Amgen INC. | $485.74 | 2019-2025 | Repatha |
| Cardiovascular Systems INC. | $474.14 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $462.47 | 2019-2023 | |
| Philips North America LLC | $426.64 | 2019-2020 | |
| Cook Medical LLC | $366.19 | 2020-2024 | Cook Celect |
| Merck Sharp & Dohme LLC | $365.36 | 2021-2025 | Verquvo |
| Cvrx, INC. | $352.51 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.55 | 2020-2023 | Lifevest |
| Heartflow, INC. | $236.67 | 2022-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $193.93 | 2022 | |
| Terumo Medical Corporation | $179.90 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.37 | 2020-2022 | |
| Abiomed | $159.56 | 2021-2025 | Impella |
| Shockwave Medical, INC | $155.36 | 2021-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Astrazeneca Pharmaceuticals LP | $137.21 | 2019-2022 | |
| Edwards Lifesciences Corporation | $129.84 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $110.22 | 2021-2025 | Rhythm Express |
| Janssen Pharmaceuticals, INC | $93.98 | 2019-2022 | |
| Amarin Pharma, INC. | $58.85 | 2019-2021 | |
| Cardinal Health 200 LLC | $55.64 | 2020 | |
| Pfizer INC. | $43.64 | 2021-2022 | |
| Lundbeck LLC | $42.73 | 2019-2020 | |
| Tactile Systems Technology INC | $30.22 | 2024 | Flexitouch Plus, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $27.92 | 2021-2022 | |
| Cordis US Corp. | $26.38 | 2023 | Radial 360 |
| Lantheus Medical Imaging, INC. | $24.03 | 2024 | |
| Biocompatibles, INC. | $21.77 | 2019 | |
| Biotronik INC. | $18.14 | 2021 | |
| Esperion Therapeutics, INC. | $14.44 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaffar Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.